Literature DB >> 32464115

Caution against corticosteroid-based COVID-19 treatment.

Chong Tang1, Yichuan Wang1, Houshan Lv2, Zhenpeng Guan3, Jin Gu4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32464115      PMCID： PMC7247780          DOI： 10.1016/S0140-6736(20)30749-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study.

Authors:  Kuo-An Lai; Wun-Jer Shen; Chyun-Yu Yang; Chung-Jung Shao; Jui-Ting Hsu; Ruey-Mo Lin
Journal:  J Bone Joint Surg Am       Date:  2005-10       Impact factor: 5.284

2.  Combined pharmacotherapy for osteonecrosis of the femoral head after severe acute respiratory syndrome and interstitial pneumonia: two and a half to fourteen year follow-up.

Authors:  Weiguo Wang; Nianfei Zhang; Wanshou Guo; Fuqiang Gao
Journal:  Int Orthop       Date:  2018-03-28       Impact factor: 3.075

3.  The influence of age, gender and treatment with steroids on the incidence of osteonecrosis of the femoral head during the management of severe acute respiratory syndrome: a retrospective study.

Authors:  K J Guo; F C Zhao; Y Guo; F L Li; L Zhu; W Zheng
Journal:  Bone Joint J       Date:  2014-02       Impact factor: 5.082

Review 4.  Corticosteroid-induced Osteonecrosis of the Femoral Head: Detection, Diagnosis, and Treatment in Earlier Stages.

Authors:  Li-Hua Liu; Qing-Yu Zhang; Wei Sun; Zi-Rong Li; Fu-Qiang Gao
Journal:  Chin Med J (Engl)       Date:  2017-11-05       Impact factor: 2.628

5.  Inhibitory effects of vitamin E on osteocyte apoptosis and DNA oxidative damage in bone marrow hemopoietic cells at early stage of steroid-induced femoral head necrosis.

Authors:  Yan-Bo Jia; Dian-Ming Jiang; Yi-Zhong Ren; Zi-Hong Liang; Zhen-Qun Zhao; Yu-Xin Wang
Journal:  Mol Med Rep       Date:  2017-02-02       Impact factor: 2.952

6.  Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience.

Authors:  Rong-Chang Chen; Xiao-Ping Tang; Shou-Yong Tan; Bi-Ling Liang; Zhuo-Yue Wan; Ji-Qian Fang; Nanshan Zhong
Journal:  Chest       Date:  2006-06       Impact factor: 9.410

7.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

8.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.

Authors:  Nanshan Chen; Min Zhou; Xuan Dong; Jieming Qu; Fengyun Gong; Yang Han; Yang Qiu; Jingli Wang; Ying Liu; Yuan Wei; Jia'an Xia; Ting Yu; Xinxin Zhang; Li Zhang
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

9.  On the use of corticosteroids for 2019-nCoV pneumonia.

Authors:  Lianhan Shang; Jianping Zhao; Yi Hu; Ronghui Du; Bin Cao
Journal:  Lancet       Date:  2020-02-12       Impact factor: 79.321

10.  Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.

Authors:  Clark D Russell; Jonathan E Millar; J Kenneth Baillie
Journal:  Lancet       Date:  2020-02-07       Impact factor: 79.321
  10 in total
  21 in total

Review 1.  Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19.

Authors:  Yanghong Ni; Aqu Alu; Hong Lei; Yang Wang; Min Wu; Xiawei Wei
Journal:  Mol Biomed       Date:  2021-01-20

Review 2.  Impact of COVID-19 on the thyroid gland: an update.

Authors:  Lorenzo Scappaticcio; Fabián Pitoia; Katherine Esposito; Arnoldo Piccardo; Pierpaolo Trimboli
Journal:  Rev Endocr Metab Disord       Date:  2020-11-25       Impact factor: 6.514

Review 3.  Current knowledge of COVID-19: advances, challenges and future perspectives.

Authors:  Yuhan Wu; Zhuobing Peng; Yongxue Yan; Jintao Hu; Yalong Wang; Xiaoyu Wang; Ruchao Peng; Daniel Watterson; Yi Shi
Journal:  Biosaf Health       Date:  2021-06-04

4.  Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study.

Authors:  Qiang Li; Weixia Li; Yinpeng Jin; Wei Xu; Chenlu Huang; Li Li; Yuxian Huang; Qingchun Fu; Liang Chen
Journal:  Infect Dis Ther       Date:  2020-09-02

Review 5.  Gut Microbiota Dysbiosis-Immune Hyperresponse-Inflammation Triad in Coronavirus Disease 2019 (COVID-19): Impact of Pharmacological and Nutraceutical Approaches.

Authors:  Carolina Ferreira; Sofia D Viana; Flávio Reis
Journal:  Microorganisms       Date:  2020-10-01

Review 6.  SARS-CoV-2 associated COVID-19 in Geriatric Population: A Brief Narrative Review.

Authors:  Jamaan Mohamad Al-Zahrani
Journal:  Saudi J Biol Sci       Date:  2020-11-05       Impact factor: 4.219

Review 7.  Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19.

Authors:  Yanghong Ni; Aqu Alu; Hong Lei; Yang Wang; Min Wu; Xiawei Wei
Journal:  Mol Biomed       Date:  2021-01-20

8.  The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19.

Authors:  Jingjing Cai; Haomiao Li; Changjiang Zhang; Ze Chen; Hui Liu; Fang Lei; Juan-Juan Qin; Ye-Mao Liu; Feng Zhou; Xiaohui Song; Jianghua Zhou; Yan-Ci Zhao; Bin Wu; Meiling He; Huilin Yang; Lihua Zhu; Peng Zhang; Yan-Xiao Ji; Guang-Nian Zhao; Zhigang Lu; Liming Liu; Weiming Mao; Xiaofeng Liao; Haofeng Lu; Daihong Wang; Xigang Xia; Xiaodong Huang; Xiang Wei; Jiahong Xia; Bing-Hong Zhang; Yufeng Yuan; Zhi-Gang She; Qingbo Xu; Xinliang Ma; Yibin Wang; Juan Yang; Xin Zhang; Xiao-Jing Zhang; Hongliang Li
Journal:  Cell Metab       Date:  2021-01-05       Impact factor: 27.287

9.  Dermatological therapies with relevance to COVID-19.

Authors:  Mansak Shishak; Rashmi Sarkar
Journal:  Dermatol Ther       Date:  2020-07-05       Impact factor: 3.858

10.  Corticosteroid-Induced Osteonecrosis in COVID-19: A Call For Caution.

Authors:  Bin Zhang; Shuixing Zhang
Journal:  J Bone Miner Res       Date:  2020-08-12       Impact factor: 6.390
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.